NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts $0.57 +0.01 (+1.23%) Closing price 04:10 PM EasternExtended Trading$0.56 0.00 (-0.35%) As of 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock NovaBay Pharmaceuticals Earnings Summary NovaBay Pharmaceuticals announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$1.37. Quarterly revenue was reported to be $2.40 million. With a trailing EPS of -$9.95, NovaBay Pharmaceuticals' earnings are expected to grow next year, from ($2.54) to ($0.55) per share. Latest Q2 Earnings DateAug. 13EstimatedActual Revenue (Aug. 13) $2.40MQ2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q)Powered by Get NovaBay Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovaBay Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNBY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NBY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NovaBay Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($2.54) EPSNext Year EPS Consensus Estimate ($0.55) EPS NovaBay Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/13/2024Q2 2024--$1.37 -$1.37-$1.37-$2.40M5/9/2024Q1 2024--$0.14 -$0.14-$0.13-$2.63M3/26/2024Q4 2023--$0.95 -$0.95-$0.57-$3.73M11/9/2023Q3 2023--$0.37 -$0.37-$0.37-$3.27M8/10/2023Q2 2023--$1.27 -$1.27-$1.27-$4.61M NovaBay Pharmaceuticals Earnings - Frequently Asked Questions When did NovaBay Pharmaceuticals announce their last quarterly earnings? NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on NBY's earnings history. How can I listen to NovaBay Pharmaceuticals's earnings conference call? The conference call for NovaBay Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read NovaBay Pharmaceuticals's conference call transcript? The conference call transcript for NovaBay Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does NovaBay Pharmaceuticals generate each year? NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded annual revenue of $14.40 million. How much profit does NovaBay Pharmaceuticals generate each year? NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded net income of -$10.61 million. NBY has generated -$9.95 earnings per share over the last four quarters. What is NovaBay Pharmaceuticals's EPS forecast for next year? NovaBay Pharmaceuticals's earnings are expected to grow from ($2.54) per share to ($0.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies PHGE Earnings KPRX Earnings BETRF Earnings DWTX Earnings ORGS Earnings PHIO Earnings SNSE Earnings BMRA Earnings CELZ Earnings NEUP Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NYSEAMERICAN:NBY) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NBY Stock Free NBY Stock Alerts